News | January 18, 2007

Biosense Webster Forges Big-Name Alliances

Jan. 19, 2007 — Biosense Webster made two agreements public this week with healthcare competitor modality giants Philips and Siemens.

On Jan. 16 the company announced it has agreed to co-develop integrated products with Philips that will simplify complex procedures to diagnose and treat irregular heartbeats, also known as arrhythmias. Two days later Biosense and Siemens announced an extension of their strategic alliance to now give Biosense Webster exclusive worldwide rights to distribute Siemens' ACUSON AcuNav ultrasound catheters to interventional cardiologists.

Biosense Websters value as a key player in the electrophysiology and interventional cardiology market is underscored by the large-scale and high-profile deals immediately out of the 2007 gate. The Siemens agreement is an expansion of an arrangement penned earlier this month that gave Biosense Webster exclusive distribution rights to market Siemens’ catheter to electrophysiologists.

Siemens says the expanded strategic alliance will enable the two companies to address the real-time imaging needs of interventional cardiologists.

Siemens AcuNav ultrasound catheters provide physicians with high quality diagnostic images and Doppler blood flow information throughout the entire heart during a cardiac catheterization procedure, the manufacturer states. Approved for marketing in 1999, AcuNav ultrasound catheters are known for state-of-the-art quality and are currently the world's leading cardiac imaging catheters, the company asserts.

"The integration of these two industry leaders, both focused on providing high quality intracardiac echocardiography products will help physicians improve care for the cardiac patient," said Robert J. Sommer, M.D., New York-Presbyterian Hospital/Columbia University Medical Center. "Clinicians are looking forward to the innovative products that this collaboration will provide to the medical community."

Biosense Webster is a key player in the electrophysiology and interventional cardiology market and Siemens is an ultrasound industry leader.

Meanwhile, the alliance between Philips and Biosense Webster will enable the creation of an interface that connects Biosense Webster’s Carto Mapping and Navigation System with Philips’ integrated Allura Xper electrophysiology (EP) Lab System — with the objective of helping reduce the amount of time required to setup and perform complex electrophysiology (EP) ablation procedures.

Carto will also be integrated with Philips’ Xcelera Cardiovascular Information Solution.

Related Content

Algorithm Steers Catheters to Right Spot to Treat Atrial Fibrillation

Using human AFib simulations, the researchers demonstrated that their technique can stop the catheter at the right target and identify the source type with a 95.25 percent success rate. This new algorithm also is effective in scarred tissue, which makes ablation more challenging, and has a 99 percent detection rate regardless of the scar size. Image courtesy of Florida Atlantic University.

News | EP Mapping and Imaging Systems | May 28, 2019
Researchers have developed the first algorithm that can locate patient-specific ablation targets for atrial...
Acutus Medical Announces Rhythm Xience Acquisition, New Partnerships at HRS 2019

Acutus Medical's acquisition of Rhythm Xience brings the Flextra steerable introducer sheath into Acutus Medical's product portfolio.

News | EP Mapping and Imaging Systems | May 17, 2019
At the 40th annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Acutus Medical announced the agreement...
Electromechanical Wave Imaging (EWI) is a new, high-frame rate 3-D rendered ultrasound technique that can noninvasively map the electromechanical activation of heart rhythm. This example shows the ECG tracings compared to the EWI image of the heart.

Electromechanical Wave Imaging (EWI) is a new, high-frame rate 3-D rendered ultrasound technique that can noninvasively map the electromechanical activation of heart rhythm. This example shows the ECG tracings compared to the EWI image of the heart.

Feature | EP Mapping and Imaging Systems | May 15, 2019 | Dave Fornell, Editor
May 15, 2019 — A new study shows electromechanical wave imaging is capable of localizing arrhythmias including atrial
Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment
News | EP Mapping and Imaging Systems | May 09, 2019
Philips announced a collaboration with Medtronic to further advance treatment of paroxysmal atrial fibrillation (PAF),...
Acutus Medical Receives FDA Clearance for Second-generation AcQMap Platform
Technology | EP Mapping and Imaging Systems | April 26, 2019
Acutus Medical announced U.S. Food and Drug Administration (FDA) clearance of its second-generation AcQMap platform,...
Acutus AcQMap Imaging System Helps Eliminate Arrhythmia With Single Ablation
News | EP Mapping and Imaging Systems | January 28, 2019
Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap advanced cardiac...
First Carto Vizigo Bi-Directional Guiding Sheath Employed on West Coast
News | EP Mapping and Imaging Systems | October 29, 2018
October 29, 2018 — Good Samaritan Hospital recently became the first hospital on the West Coast to utilize the Carto
BioSig Technologies Announces FDA 510(k) Clearance for Pure EP System
Technology | EP Mapping and Imaging Systems | August 14, 2018
BioSig Technologies Inc. announced that the company received 510(k) clearance for its first product, Pure EP System,...
Volta Medical Brings Artificial Intelligence to Cardiac Electrophysiology

Image courtesy of Intermountain Medical Center Heart Institute

News | EP Mapping and Imaging Systems | June 12, 2018
Volta Medical, out of Marseille, France, has developed the first artificial intelligence (AI) software to guide...
APN Health Releases Navik 3D Cardiac Mapping System
Technology | EP Mapping and Imaging Systems | May 03, 2018
May 3, 2018 — APN Health LLC announced its Navik 3D...
Overlay Init